Vancocin CIP 500 mg Tablet (Vancomycin Hydrochloride)

Adult dosage

For adults, administer 500 mg intravenously every 6 hours or 1 g intravenously every 12 hours. When taken orally, a total daily dosage of 500-2000 mg should be divided into 3-4 doses for 7-10 days, with a total daily dosage not exceeding 2 g.

Children's dosage

For children, administer 10 mg/kg intravenously every 6 hours. For infants, administer 10-15 mg/kg intravenously every 12 hours. For very young children and neonates, 1 dose of 1

This medication should not be used in patients with a history of severe allergic reactions or shock due to this medication or similar peptide or aminoglycoside antibiotics. It should be used with caution in patients with hearing loss or renal dysfunction, particularly in patients with weakened renal function, who should frequently check blood levels to adjust the dosage. During the administration of this medication, various side effects such as neurological symptoms, gastrointestinal symptoms, blood abnormalities, changes in hearing, liver and kidney function abnormalities, and skin reactions may occur; therefore, symptoms should be closely monitored. Particularly, if severe rashes or mucosal lesions occur, usage should be immediately discontinued and healthcare professionals should be notified. Rapid infusion of this medication may cause hypotension, flushing, and muscle cramps, so it is important to administer it slowly. Rarely, serious gastrointestinal infections such as pseudomembranous colitis can occur due to antibiotic use; therefore, if symptoms like diarrhea, abdominal pain, or fever persist, it should be reported immediately. Women who are pregnant or breastfeeding should discuss potential effects on the fetus or newborn with a healthcare provider before using this medication; if breastfeeding, it is advisable to avoid administering the drug or to discontinue breastfeeding. Pediatrics, especially premature infants or neonates, should be used with increased caution as renal function is immature, which may cause elevated blood concentrations of this medication. Elderly patients are likely to have diminished renal function; therefore, renal function should be assessed before and during treatment, and dosages should be adjusted as necessary. This medication must be administered only via intravenous injection; administering it via intramuscular or other inappropriate methods can cause tissue damage or pain. When used in combination with other medications, the risk of adverse effects may increase due to interactions, so it is essential to inform healthcare providers of all medications being taken and to monitor closely. In the case of overdose, renal damage and hearing loss may occur, and appropriate treatment and supportive therapy may be required. It is crucial to administer this medication for only the minimum duration necessary for infection treatment to prevent the emergence of resistant bacteria.

Serious side effects

Shock, anaphylactic symptoms, hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, exfoliative dermatitis, bullous dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, severe skin reactions, hypotension, wheezing, respiratory distress, drug hypersensitivity syndrome, acute generalized exanthematous pustulosis, severe skin reactions, Red Man syndrome, liver abnormalities (jaundice), acute renal failure, liver.

Mild side effects

• Loose stools
• diarrhea
• nausea
• vomiting
• abdominal pain
• decreased red blood cells
• decreased white blood cells
• decreased platelets
• increased eosinophils
• dizziness

This medication should be stored in a sealed container to prevent contact with air and kept at a temperature between 1 and 30 degrees Celsius. Therefore, avoid storing it in excessively hot or cold places.

Appearance

A white to light yellow-brown freeze-dried sterile injection contained in a colorless transparent glass vial.

Package unit

1 vial